Kolb MRJ - Search Results

1

Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases.

Isshiki T, Naiel S, Vierhout M, Otsubo K, Ali P, Tsubouchi K, Yazdanshenas P, Kumaran V, Dvorkin-Gheva A, Kolb MRJ, Ask K. Isshiki T, et al. Among authors: kolb mrj. Pharmacol Ther. 2024 Jan;253:108578. doi: 10.1016/j.pharmthera.2023.108578. Epub 2023 Dec 15. Pharmacol Ther. 2024. PMID: 38103794 Review.

2

Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" BALB/c mouse lungs.

Bonniaud P, Martin G, Margetts PJ, Ask K, Robertson J, Gauldie J, Kolb M. Bonniaud P, et al. Am J Respir Cell Mol Biol. 2004 Nov;31(5):510-6. doi: 10.1165/rcmb.2004-0158OC. Epub 2004 Jul 15. Am J Respir Cell Mol Biol. 2004. PMID: 15256388

3

TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis.

Bonniaud P, Margetts PJ, Ask K, Flanders K, Gauldie J, Kolb M. Bonniaud P, et al. J Immunol. 2005 Oct 15;175(8):5390-5. doi: 10.4049/jimmunol.175.8.5390. J Immunol. 2005. PMID: 16210645

4

Targeting genes for treatment in idiopathic pulmonary fibrosis: challenges and opportunities, promises and pitfalls.

Ask K, Martin GE, Kolb M, Gauldie J. Ask K, et al. Proc Am Thorac Soc. 2006 Jun;3(4):389-93. doi: 10.1513/pats.200602-021TK. Proc Am Thorac Soc. 2006. PMID: 16738206 Review.

5

Gene therapy for pulmonary diseases.

Kolb M, Martin G, Medina M, Ask K, Gauldie J. Kolb M, et al. Chest. 2006 Sep;130(3):879-84. doi: 10.1378/chest.130.3.879. Chest. 2006. PMID: 16963689 Review.

6

Smad3 signaling involved in pulmonary fibrosis and emphysema.

Gauldie J, Kolb M, Ask K, Martin G, Bonniaud P, Warburton D. Gauldie J, et al. Proc Am Thorac Soc. 2006 Nov;3(8):696-702. doi: 10.1513/pats.200605-125SF. Proc Am Thorac Soc. 2006. PMID: 17065376 Free PMC article. Review.

7

Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF-beta3.

Ask K, Bonniaud P, Maass K, Eickelberg O, Margetts PJ, Warburton D, Groffen J, Gauldie J, Kolb M. Ask K, et al. Int J Biochem Cell Biol. 2008;40(3):484-95. doi: 10.1016/j.biocel.2007.08.016. Epub 2007 Sep 6. Int J Biochem Cell Biol. 2008. PMID: 17931953 Free PMC article.

8

The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. Moeller A, et al. Int J Biochem Cell Biol. 2008;40(3):362-82. doi: 10.1016/j.biocel.2007.08.011. Epub 2007 Aug 30. Int J Biochem Cell Biol. 2008. PMID: 17936056 Free PMC article. Review.

9

Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis.

Moeller A, Gilpin SE, Ask K, Cox G, Cook D, Gauldie J, Margetts PJ, Farkas L, Dobranowski J, Boylan C, O'Byrne PM, Strieter RM, Kolb M. Moeller A, et al. Am J Respir Crit Care Med. 2009 Apr 1;179(7):588-94. doi: 10.1164/rccm.200810-1534OC. Epub 2009 Jan 16. Am J Respir Crit Care Med. 2009. PMID: 19151190

10

VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats.

Farkas L, Farkas D, Ask K, Möller A, Gauldie J, Margetts P, Inman M, Kolb M. Farkas L, et al. J Clin Invest. 2009 May;119(5):1298-311. doi: 10.1172/JCI36136. Epub 2009 Apr 20. J Clin Invest. 2009. PMID: 19381013 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters